Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
MorphoSys AG (0001340243)
Standardized SEC financial data for MorphoSys AG — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001340243 · Pharmaceutical Preparations.
Net margin
-223.1%
Revenue growth (YoY)
0.2%
Return on equity
-386.8%
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
€
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
€76.4M
€71.8M
€327.7M
€179.6M
€278.3M
€238.3M
Cost of revenue
€1.8M
€12.1M
€9.2M
€32.2M
€48.6M
€58.4M
Gross profit
€74.6M
€59.7M
€318.5M
€147.4M
€229.6M
€179.9M
R&D expense
€106.4M
€108.4M
€139.4M
€225.2M
€297.8M
€283.6M
SG&A expense
€21.9M
€36.7M
€107.7M
€121.5M
€92.4M
€81.4M
Interest expense
—
€91K
€1.0M
€2.4M
€2.8M
€4.7M
Net income
-€56.2M
-€103.0M
€97.9M
-€514.5M
-€151.1M
-€189.7M
Standardized from MorphoSys AG's SEC filings — per-share figures split-adjusted. Full history via the API.